Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

2.

On all CAR-T products, the FDA is calling for a new boxed warning.

3.

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

4.

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

5.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot